Liver disorders in inflammatory bowel disease. - Wikidata - wikimedia - TriplyDB

Liver disorders in inflammatory bowel disease.

Liver disorders in inflammatory bowel disease.

http://www.wikidata.org/entity/Q42122089

about

Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.Clinical Features and Extraintestinal Manifestations of Crohn Disease in Children A conceptual and practical approach to haemostasis in paediatric liver disease.Hepatic manifestations of inflammatory bowel diseases.An unusual cause of febrile hepatitis.Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.The Sasa quelpaertensis Leaf Extract Inhibits the Dextran Sulfate Sodium-induced Mouse Colitis Through Modulation of Antioxidant Enzyme Expression.Dexamethasone-loaded Polymeric Nanoconstructs for Monitoring and Treating Inflammatory Bowel Disease.Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

P2860

Q33709456-9F83AF8E-35E2-4C74-91A8-3986649C1DC6 Q36903569-86AF2C85-7975-4E23-997F-72EC41F411F3 Q36967764-C2956EEE-A727-478B-AD44-3722F9FB091D Q37317444-B68EAA44-9666-4DE7-8A6D-7F544DFBB34E Q37585284-5FDACD0F-54CB-4F2C-946B-9E368CF40733 Q38788396-C66123EE-4EDC-4FA6-931A-58C48B5DD746 Q38814158-2A6EC17D-1CF5-4F60-9404-BD504855158A Q40149987-9173B00F-7D2C-4DF8-8832-302E6FF9D6A8 Q41151384-BC3F8838-4FDF-42A0-984D-3E6C80C5B589 Q41375583-4D6BE766-944F-4A50-A464-749283EBD861 Q43652013-17BDEED3-A634-42FD-A969-ED7CA5D9C230 Q55114620-9D73FA16-347B-454A-BFF7-7803691C998F

P2860

Liver disorders in inflammatory bowel disease.

http://www.wikidata.org/entity/Q42122089

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Liver disorders in inflammatory bowel disease.

@en

Liver disorders in inflammatory bowel disease.

@nl

type

label

Liver disorders in inflammatory bowel disease.

@en

Liver disorders in inflammatory bowel disease.

@nl

prefLabel

Liver disorders in inflammatory bowel disease.

@en

Liver disorders in inflammatory bowel disease.

@nl

P1433

Q42122089-E09FD9EA-108F-4C1C-9B59-60414737EC35

P1476

Q42122089-7864547F-BBA1-41BD-8C5D-3DB8186928DC

P2093

Q42122089-7D12B7AA-0F6E-49E6-9802-D80E292B243E

Q42122089-8CC46869-F9AB-4DB1-A07D-FA8B427E6CC1

Q42122089-9989D5FA-EC49-4A0A-9FFE-C6CFFAAF225E

P2860

Q42122089-00569A52-B4EB-49BA-8D90-7E3771723843

Q42122089-0372FDD3-6EE9-46E9-AD3A-7C9B6730585B

Q42122089-03F39565-746A-4098-9ECC-476A11689BD1

Q42122089-05EA4642-85CB-4874-A1F9-4465F8BE7E11

Q42122089-07BB513A-D8B8-459F-9FDA-9634B3BE6672

Q42122089-0A055B96-3DB0-4551-B5C1-1AD553EE48A8

Q42122089-0D557C03-9637-4641-A428-F16C80DA6ACB

Q42122089-0FA897B5-17C4-47D9-8CA5-A78AE0D871DB

Q42122089-1783E01D-F633-46B7-8569-393BF5DC8860

Q42122089-20522E45-74A7-4DD9-BCB5-7E6E7EA239D2

P304

Q42122089-AC2D4075-B551-479C-B992-9A7635E659EC

P31

Q42122089-A54C521D-D76E-44A2-921B-5261962B37E2

P356

Q42122089-A4729133-EAE2-4387-B32A-E2D61D13971A

P478

Q42122089-8038FB1F-6B5C-46DB-830D-83376144083B

P577

Q42122089-98A8FFAA-8465-4554-BC2E-BE8F4D7AC019

P5875

Q42122089-5716C64A-6AAA-48F1-A27D-595D0D9BA6BE

P698

Q42122089-F19194A9-4F85-4EE6-BB0D-311AB76618F7

P921

Q42122089-A52ED84F-B505-47CD-AA87-79AEF6498710

Q42122089-CFB4DD8E-9009-41C8-BCB4-3D81F1A82F06

P932

Q42122089-18492B7B-9411-4591-A168-A4F4C7F68F3D

P356

P1433

Gastroenterology research and practice

P1476

Liver disorders in inflammatory bowel disease.

@en

P2093

Kadakkal Radhakrishnan

http://www.w3.org/2001/XMLSchema#string

Suraj Thangada

http://www.w3.org/2001/XMLSchema#string

Victor Uko

http://www.w3.org/2001/XMLSchema#string

P2860

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

Azathioprine induced nodular regenerative hyperplasia in IBD patients.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

P304

642923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/642923

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223986902

http://www.w3.org/2001/XMLSchema#string

P698

22474447

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3296398

http://www.w3.org/2001/XMLSchema#string